Skip to content
TrialScanner

NCT05694364

Dose Escalation/Dose Expansion Study of PRGN-3007 UltraCAR-T Cells in Patients With Advanced Hematologic and Solid Tumor Malignancies

Phase 1CompletedPGENCollaborator

Registry record

Lead sponsor
H. Lee Moffitt Cancer Center and Research Institute
Conditions
Chronic Lymphocytic Leukemia; Mantle Cell Lymphoma; Acute Lymphoblastic Leukemia; Diffuse Large B Cell Lymphoma; Triple Negative Breast Cancer Malignancies
Primary completion
Apr 18, 2024Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT05694364 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.